Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial protocol
Study results will provide a first critical step towards potential intervention for prevention of return to MU among postpartum individuals. Completion of this trial will set the stage for a large-scale efficacy trial.
Authors
- Marcela Carolina Smid (ORCID: https://orcid.org/0000-0003-3010-0662)
- Kristi Carlston (ORCID: https://orcid.org/0000-0002-2297-9702)
- Amanda A. Allshouse (ORCID: https://orcid.org/0000-0003-0109-7193)
- Elysha Cash (ORCID: https://orcid.org/0000-0002-6444-233X)
- Jasmin E. Charles
- Adam J. Gordon (ORCID: https://orcid.org/0000-0002-2453-8871)
- Gerald Cochran (ORCID: https://orcid.org/0000-0002-0153-0252)
- Stephanie Castro
- Natasha Seliski (ORCID: https://orcid.org/0000-0001-9375-1767)
- Grace Humiston
- Marie J. Gibson
- Elizabeth L. Turner
Institutions
- University of Utah (US)
- Huntsman Cancer Institute (US)
- VA Salt Lake City Healthcare System (US)
- Utah Department of Health (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.conctc.2024.101359
- Citations
- 1
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences